Over at his blog this week, the Washington Post’s Ezra Klein discusses the impact of genomic medicine on what he calls "the coming explosion in healthcare inequality." According to Klein, should genome-based medicine come to fruition, such that "we’ll be able to use the information contained in an individual's DNA sequence to target their therapies much more precisely," healthcare inequality will increase.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.